STAT+: Pharmalittle: Judge reverses Purdue Pharma bankruptcy plan; FDA eases access restrictions on abortion pills
And so, another working week will soon draw to a close. Not a moment too…
Author: STAT
The tragedy of Johnson & Johnson’s Covid vaccine
Johnson & Johnson’s Covid vaccine was going to be the shot for the world. Now,…
Opinion: It’s not the mission of universities to perpetuate inequity. Why do Emory and others do that?
As billions of people in the Global South continue to confront Covid-19 unprotected because they…
Opinion: STAT+: 8 reasons ‘move fast and break things’ doesn’t work for health care companies
Entrepreneurs at tech startups are likely to hear the Mark Zuckerberg adage that it’s important…
STAT+: Prescription apps to treat disease face uncertainty as they fight for insurance coverage
In August, Pear Therapeutics, the company at the forefront of creating prescription software to treat…
Preliminary laboratory data hint at what makes Omicron the most superspreading variant yet
Omicron is now in 77 countries, and moving faster than any previous strain of the…
STAT+: Judge reverses $4.5 billion Purdue Pharma bankruptcy settlement
A federal court judge has reversed the hotly contested Purdue Pharma bankruptcy plan after deciding…
FDA lifts key restriction on abortion pill, allowing it to be obtained by mail
Amid national furor over abortion, the Food and Drug Administration permanently removed a controversial restriction…
CDC advisory panel, concerned about rare side effects tied to J&J vaccine, gives preferential nod to mRNA shots
A panel that advises the Centers for Disease Control and Prevention gave a rare preferential…
Listen: Covid in 2022, J.P. Morgan bows to pressure, & the year in review
Will we be getting boosters forever? Does Jamie Dimon hate Zoom? And how do you…
STAT+: Biden administration seeks a legislative path for novel antibiotic drug development
Amid rising concerns over antibiotic resistance, the U.S. Department of Health and Human Services is…
Opinion: Health care workers’ suffering goes far beyond burnout. Self-care isn’t the cure
We survived the pandemic’s early days with purpose-fueled adrenaline. Working in the epicenter of the…
STAT+: FDA rebukes Endo for ‘anticompetitive practices,’ asks FTC to investigate
In an unusual move, the U.S. Food and Drug Administration has openly suggested that a…
Newly public health tech startups struggle, a ticking clock for Talkspace, & decentralized depression trial
You’re reading the web edition of STAT Health Tech, our guide to how tech is…
STAT+: Pharmalittle: Biogen to start large trial to confirm Alzheimer’s drug benefits; FDA to decide on easier access to abortion pill
Top of the morning, and a fine one, it is. The sun is trying to…
As Aduhelm faces doubts, Biogen plans another pivotal trial for 2022
Biogen said Thursday that it expects to begin a large clinical trial next May to…
Opinion: Why the big questions about drug prices are rarely asked: It’s hard to do
Public debate over legislation to allow Medicare to negotiate the price of drugs has been…
Q&A: After finding few answers about her own rare cancer, Corrie Painter is crowdsourcing to fill cancer ‘data vacuum’
In May 2010, Corrie Painter received shocking news: She had angiosarcoma, an extremely rare cancer…
STAT+: Medicine’s first autonomous AI could prevent blindness due to diabetes — if it can reach those most in need
Once feared as a job-erasing technology devoid of clinical nuance, autonomous artificial intelligence in medicine…
Poll: Omicron is forcing Americans to rethink some — but not all — of their holiday plans
Four out of five vaccinated Americans say they will still wear a mask inside public…
STAT+: Health tech’s sky-high projections in 2021 have already been punctured
The health technology sector has seen extraordinary enthusiasm among private and public investors this year….
Virtual Event: The ASH Recap, Live!
Editor’s note: A livestream of the event will be embedded below at 1 p.m. ET….
STAT+: Pharmalittle: Califf sails through hearing for top FDA job; J.P. Morgan goes virtual after big biotechs pull out
Hello, everyone, and how are you today? We are doing just fine, thank you, since…
Bowing to pressure, J.P. Morgan says its health care conference will be virtual
The J.P. Morgan Healthcare Conference, biotech’s biggest annual conference, will be virtual, the bank said…
Opinion: Listen: A parent on advocating for people with autism who can’t advocate for themselves
Alison Singer learned how to advocate for a child with autism by watching her mother…
STAT+: Biotech investor Eli Casdin on biotech’s bad December
Biotech investors are having some not-so-happy holidays. In the last few months, several major funds…
Opinion: Many states aren’t ready for a 988 crisis line. The deadline is looming
America’s fragile mental health safety net all too often leaves people nowhere to turn but…
How much naloxone is needed to reverse an opioid overdose? New high-dose treatments are raising questions
At a time when a record number of Americans have died from drug overdoses —…
Will we always need Covid-19 boosters? Experts have theories
With the world facing the latest in a seemingly endless stream of coronavirus variants —…
Copy of Will we always need Covid-19 boosters? Experts have theories
With the world facing the latest in a seemingly endless stream of coronavirus variants —…
.jpg)
Califf sails through confirmation hearing for FDA job, despite tensions over opioids
WASHINGTON — Robert Califf escaped largely unscathed from a two-hour hearing Tuesday vetting him to…
STAT+: Moderna, Amgen among biotech heavyweights pulling out of JPM conference over Covid concerns
Some of the biggest names in biotechnology, including Amgen, Moderna, and Sarepta Therapeutics, have pulled…
Telehealth’s 2021 report card & CVS leans on digital health
You’re reading the web edition of STAT Health Tech, our guide to how tech is…
Leading Covid-19 experts on the questions they want answered about Omicron
For some Covid experts, what’s most unsettling about the Omicron variant is all the uncertainty…
STAT+: Pharmalittle: Pfizer Covid pill retains 89% efficacy in full study; Senate committee holds hearing on FDA commissioner
Rise and shine, folks, another busy day is on the way. We can tell, thanks…
CDC data indicate Omicron is starting to eat into Delta’s U.S. dominance
The Omicron variant is starting to eat into Delta’s dominance in the United States. The…
STAT+: STAT+ Conversation: The Whitest Medical Specialty
Editor’s note: A livestream of the conversation will be embedded below at 2 p.m. ET….
.jpg)
Pfizer’s Covid pill remains 89% effective in final analysis, company says
Paxlovid, Pfizer’s pill to treat Covid-19, retained its 89% efficacy at preventing hospitalization and death…
Opinion: FDA’s outdated Birth Control Guide blocks access to the innovations the agency has approved
Every day, women in the United States are routinely denied access to the latest birth…
Watch: A rebel with a cause: As a mentor and a leader, this Black orthopedic surgeon fights to diversify his field
A rare Black orthopedic surgeon in an overwhelmingly white specialty, Eric Carson has spent decades…
STAT+: Oregon wants to get out of covering drugs like Aduhelm in Medicaid
WASHINGTON — Oregon is gearing up to ask the Biden administration if its Medicaid program…
STAT+: Hospitals just dodged a bullet in Democrats’ major spending package. Can they sidestep a bigger one?
WASHINGTON — Hospitals and their lobbyists in Washington just wriggled their way out of a…
Orthopedic surgeons pride themselves on fixing things. Can they fix their own field’s lack of diversity?
This is part two of a STAT investigation on the lack of diversity in orthopedic…
As a Logic song topped the charts, helpline saw more calls and fewer suicides
During the time that a song whose title is the number of a national suicide…
STAT+: Feeling remote: Coalition of pharma regulators look to complement on-site inspections beyond Covid
Nearly two years after the Covid-19 pandemic prompted remote inspections of pharmaceutical production plants, an…
STAT+: Pharmalittle: Pfizer to pay $6.7 billion for Arena and a bowel disease drug; ASH brings flood of data readouts
Good morning, everyone, and welcome to another working week. We hope the weekend respite was…
STAT+: More potent version of Global Blood sickle-cell drug improves hemoglobin response in small study
Global Blood Therapeutics said Monday that an experimental treatment for sickle cell disease nearly doubled…
STAT+: In a do-over study, Bellus Health cough treatment shows positive results
Results released Monday from a Phase 2 study of a chronic cough treatment being developed…
Opinion: Don’t let ‘shelved assets’ gather dust. Make them into new lifesaving drugs
Life-science companies have changed the world with the breakthrough vaccines and therapeutics they created —…
We have enough Covid vaccines for most of the world. But rich countries are stockpiling more than they need for boosters
Two years since SARS-CoV-2 first passed into humans, manufacturers have created enough vaccines to inoculate…